The University of Southampton
University of Southampton Institutional Repository

Patients with diabetes are at higher risk for severe illness from COVID-19

Patients with diabetes are at higher risk for severe illness from COVID-19
Patients with diabetes are at higher risk for severe illness from COVID-19
The World Health Organization recently declared the outbreak of severe acute respiratory syndrome coronavirus 2 disease (COVID-19) a global pandemic (1). It is known that people with diabetes have a higher overall risk of infection resulting from multiple perturbations of innate immunity (2). Presently, it remains uncertain whether people with diabetes are also at higher risk of infection and, especially, at greater severity of illness associated with COVID-19. A recent meta-analysis of 30 observational studies (most of which were preprint studies that have yet to be reviewed) showed that pre-existing diabetes is significantly associated with poorer in-hospital outcomes (3), but none of the included studies have examined whether the impact of diabetes on COVID-19 severity is independent of age, sex and metabolic comorbidities, such as obesity and hypertension. Therefore, in this retrospective study, we aimed to examine the association between diabetes and severity of COVID-19 illness (irrespective of metabolic comorbidities) among in-patients with confirmed COVID-19.
1262-3636
335-337
Targher, Giovanni
043e0811-b389-4922-974e-22e650212c5f
Mantovani, Alessandro
19fc8a1f-60fe-403a-b70e-6b6884929e03
Wang, Xiao-Bo
d24e6189-f5af-4c25-bc10-a2b7b228bb6e
Yan, Hua-Dong
613fd2fa-add0-42cc-bd0d-573916568ee7
Sun, Qing-Feng
5a583638-197b-4b9e-9803-40f6d1170489
Pan, Ke-Hua
41d18c1a-5bdc-4f13-a2c5-caeef865eaf3
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
Zheng, Kenneth I.
353d1406-0990-485f-ae70-4b2a1c65e98d
Chen, Yong-Ping
1986f9c8-dcd1-421e-bce9-771fa87b8638
Eslam, Mohammed
27e7ea69-a20e-46e4-a8b5-0caa4444ce30
George, Jacob
92f23096-09e6-430d-bdb5-a234ea81db75
Zheng, Ming-Hua
643cd966-ad9d-4176-9284-9b1f84ab9189
Targher, Giovanni
043e0811-b389-4922-974e-22e650212c5f
Mantovani, Alessandro
19fc8a1f-60fe-403a-b70e-6b6884929e03
Wang, Xiao-Bo
d24e6189-f5af-4c25-bc10-a2b7b228bb6e
Yan, Hua-Dong
613fd2fa-add0-42cc-bd0d-573916568ee7
Sun, Qing-Feng
5a583638-197b-4b9e-9803-40f6d1170489
Pan, Ke-Hua
41d18c1a-5bdc-4f13-a2c5-caeef865eaf3
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
Zheng, Kenneth I.
353d1406-0990-485f-ae70-4b2a1c65e98d
Chen, Yong-Ping
1986f9c8-dcd1-421e-bce9-771fa87b8638
Eslam, Mohammed
27e7ea69-a20e-46e4-a8b5-0caa4444ce30
George, Jacob
92f23096-09e6-430d-bdb5-a234ea81db75
Zheng, Ming-Hua
643cd966-ad9d-4176-9284-9b1f84ab9189

Targher, Giovanni, Mantovani, Alessandro, Wang, Xiao-Bo, Yan, Hua-Dong, Sun, Qing-Feng, Pan, Ke-Hua, Byrne, Christopher, Zheng, Kenneth I., Chen, Yong-Ping, Eslam, Mohammed, George, Jacob and Zheng, Ming-Hua (2020) Patients with diabetes are at higher risk for severe illness from COVID-19. Diabetes & Metabolism, 46 (4), 335-337. (doi:10.1016/j.diabet.2020.05.001).

Record type: Letter

Abstract

The World Health Organization recently declared the outbreak of severe acute respiratory syndrome coronavirus 2 disease (COVID-19) a global pandemic (1). It is known that people with diabetes have a higher overall risk of infection resulting from multiple perturbations of innate immunity (2). Presently, it remains uncertain whether people with diabetes are also at higher risk of infection and, especially, at greater severity of illness associated with COVID-19. A recent meta-analysis of 30 observational studies (most of which were preprint studies that have yet to be reviewed) showed that pre-existing diabetes is significantly associated with poorer in-hospital outcomes (3), but none of the included studies have examined whether the impact of diabetes on COVID-19 severity is independent of age, sex and metabolic comorbidities, such as obesity and hypertension. Therefore, in this retrospective study, we aimed to examine the association between diabetes and severity of COVID-19 illness (irrespective of metabolic comorbidities) among in-patients with confirmed COVID-19.

Text
COVID-19 diabetes revised R1 - Accepted Manuscript
Download (42kB)

More information

Accepted/In Press date: 11 May 2020
e-pub ahead of print date: 13 May 2020
Published date: 1 September 2020

Identifiers

Local EPrints ID: 440661
URI: http://eprints.soton.ac.uk/id/eprint/440661
ISSN: 1262-3636
PURE UUID: 3a639829-126c-46e0-826e-59d29ed50756
ORCID for Christopher Byrne: ORCID iD orcid.org/0000-0001-6322-7753

Catalogue record

Date deposited: 13 May 2020 16:33
Last modified: 17 Mar 2024 05:33

Export record

Altmetrics

Contributors

Author: Giovanni Targher
Author: Alessandro Mantovani
Author: Xiao-Bo Wang
Author: Hua-Dong Yan
Author: Qing-Feng Sun
Author: Ke-Hua Pan
Author: Kenneth I. Zheng
Author: Yong-Ping Chen
Author: Mohammed Eslam
Author: Jacob George
Author: Ming-Hua Zheng

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×